Discover and read the best of Twitter Threads about #CargoCultScience
Most recents (1)
Cytodyn ($CYDY) has put out yet another press release touting "strong results" from their triple negative breast cancer (TNBC) Leronlimab research and their intent to "evolve into an oncology-focused company. As a TNBC patient & advocate (NOT an investor), I have some questions. 
Headline mentions results from 30 mTNBC patients. How many mTNBC patients in total have been approved for Cytodyn trials? How many have received Leronlimab, including via EIND, EUA, phase I/II trial, compassionate use, etc? How many have died?
NCT03838367 How can a 30-pt single arm (no control group) study make conclusions re survival, PFS or OS? Increase in survival compared to WHAT, exactly? Historical mean overall survival varies widely.
